Noninvasive diagnostic tool for identification of NASH by visualizing hepatic steatosis and inflammation

Non-alcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-associated fatty liver disease (MAFLD), is spectrum of diseases that ranges from non-alcoholic fatty liver (NAFL) to non-alcoholic steatohepatitis (NASH).

COVID-19 hospitalization linked to long-term organ damage and mortality

Researchers determine the risk of long-term health complications following recovery from COVID-19.

March 7, 2025

SNK-396 by Synerk for Lipid Disorders: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

July 1, 2023

Updated: Exscientia CEO brought down by allegations of inappropriate employee relationships, in blow to AI pioneer

Over the last decade, Andrew Hopkins emerged as a public leader of the AI biotech field, jumping from a professor at a Scottish university to

February 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.